3-Dimethylaminopropylamine

We are 3-Dimethylaminopropylamine CAS:109-55-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:3-Dimethylaminopropylamine
CAS.NO:109-55-7
Synonyms:3-Dimethylaminopropylamine
3-(N,N-dimethylamino)prop-1-ylamine
N,N-dimethyl-propane-1,3-diamine
N,N-Dimethyltrimethylenediamine
N,N-Dimethyl-1,3-propanediamine
3-(dimethylamino)-n-propylamine
 
Physical and Chemical Properties:
Density 0.81
Boiling Point 133 ºC
Melting Point -60 °C
Molecular Formula C5H14N2
Molecular Weight 102.178
Flash Point 32 ºC
Vapour density 3.6 (vs air)
Vapour Pressure 10.1±0.2 mmHg at 25°C
Index of Refraction 1.434-1.436
 
Specification:
Appearance:Colourless clear liquid
Assay:≥99.5%
Colour:≤20 Hazen
Moisture:≤0.2%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Propamocarb(CAS:24579-73-5).

3-Dimethylaminopropylamine


Related News: Advanced intermediate suppliers not only have strong bargaining power for junior suppliers, but more importantly, because they undertake the production of advanced intermediates with high technical content and maintain closer ties with multinational companies, raw materials Price fluctuations have little effect on it.Ácido (1-aminoetil) fosfínico CAS:74333-44-1 This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.1617-90-9 Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as “bulk pharmaceutical chemicals (BPCs).”2,3-Dimethyl-6-Nitro-2H-Indazole Fate Therapeutics has exclusively licensed from MSK foundational intellectual property covering the production and composition of iPSC-derived T cells.Beta Bionics is committed to obtaining regulatory approval and commercializing all three iLet configurations.

Related Products
Product Name
3-Bromofluoranthene View Details
Diprotin A View Details
Methyl 5-chloro-3-[(2-methoxy-2-oxoethyl)sulfamoyl]-2-thiopheneca rboxylate View Details
2-Amino-6-fluorobenzonitrile manufacturer 4-Pentylbenzeneboronic acid manufacturer 3,5-Dimethylpiperidine manufacturer 5-Nitroindole manufacturer Dynorphin (1-17) manufacturer